In 2008, the Alzheimer’s Association opened a new door to support the dementia research community by creating the International Society to Advance Alzheimer's Research and Treatment (ISTAART).
Researchers and clinicians
Today's researchers join ISTAART to strengthen their scientific knowledge and network with their peers. Members enjoy exclusive benefits, participate in networking events and collaborate on papers and projects with fellow peers through participation in a Professional Interest Area (PIA).
Students and new investigators
The Association recognizes that the future of Alzheimer's research relies on students and those starting their careers in the field. ISTAART provides opportunities for networking, financial support opportunities to attend the Alzheimer's Association International Conference and mentorship.
The ISTAART Advisory Council is a select group of Alzheimer's and dementia experts representing a variety of research disciplines.
Chair, Jeffrey Kaye, M.D.
Oregon Health and Science University, Portland, Ore., Professor of Neurology and Biomedical Engineering
Layton Aging & Alzheimer's Disease Center, Portland, Ore., Director
Oregon Center for Aging & Technology, Portland, Ore., Director
Dr. Kaye directs the Layton Aging and Alzheimer's Disease Center at OHSU and the Portland Veterans Affairs Medical Center. He also directs the Oregon Center for Aging and Technology (ORCATECH). Dr. Kaye's research focuses on the question of why some individuals remain protected from dementia at advanced ages while others succumb to it much earlier. The centerpiece of his studies is the ongoing Oregon Brain Aging Study, established in 1989. He currently leads a large NIH study using technologies to assess seniors in their homes to detect cognitive decline.
Vice Chair, Sandra E. Black, M.D., FRCPC
University of Toronto, Department of Medicine, Toronto, Ontario, Brill Chair in Neurology
Sunnybrook Research Institute, Toronto, Ontario, Neuroscience Program Research Director
Dr. Black's research interests include stroke recovery and vascular cognitive impairment, diagnosis of dementia, and the use of neuroimaging to study brain-behavior relationships. She has published more 350 papers and is actively engaged in clinical trials of stroke and stroke recovery, Alzheimer's, and vascular cognitive impairment. In 2001, she received the Mel Silverman Award for Outstanding Mentorship from the University of Toronto's Institute of Medical Science, and in 2009, the University of Toronto, Department of Medicine Mentorship Award.
Sylvie Belleville, Ph.D.
University Institute of Geriatrics of Montréal, Quebec, Canada
Immediate Past Chair, Steven T. DeKosky, M.D.
University of Florida, Gainesville, Fla., United States
Lis Evered, Ph.D.
University of Melbourne; St Vincent's Hospital, Melbourne, Australia
Howard Feldman, M.D, FRCP (C)
University of British Columbia, Vancouver, BC, Canada
Karl Herrup, Ph.D.
Hong Kong University of Science and Technology, Clear Water Bay, Kowloon, Hong Kong
Prof. Dr. Frank Jessen
University Hospital Cologne, Köln, Germany
MSAC Vice-Chair Liaison, David Knopman, M.D.
Mayo Clinic, Rochester, Minn., United States
Gil Rabinovici, M.D.
University of California, San Francisco, Calif., United States
Mary Sano, Ph.D.
Alzheimer Disease Research Center, Mount Sinai School of Medicine, New York, New York, United States
Jonathan M. Schott, BSc, M.D., FRCP
Dementia Research Centre, Institute of Neurology, University College, London, United Kingdom
Wiesje M. van der Flier, Ph.D.
Alzheimer Center, VU University Medical Center, Amsterdam, The Netherlands
To increase the rate of progress of Alzheimer’s and dementia research.
ISTAART is a professional society of the Alzheimer’s Association, representing scientists, physicians and other dementia professionals active in researching and understanding the causes and treatments of Alzheimer's disease and other dementias.